Unknown

Dataset Information

0

Mutations in TBCK, Encoding TBC1-Domain-Containing Kinase, Lead to a Recognizable Syndrome of Intellectual Disability and Hypotonia.

ABSTRACT: Through an international multi-center collaboration, 13 individuals from nine unrelated families and affected by likely pathogenic biallelic variants in TBC1-domain-containing kinase (TBCK) were identified through whole-exome sequencing. All affected individuals were found to share a core phenotype of intellectual disability and hypotonia, and many had seizures and showed brain atrophy and white-matter changes on neuroimaging. Minor non-specific facial dysmorphism was also noted in some individuals, including multiple older children who developed coarse features similar to those of storage disorders. TBCK has been shown to regulate the mammalian target of rapamycin (mTOR) signaling pathway, which is also stimulated by exogenous leucine supplementation. TBCK was absent in cells from affected individuals, and decreased phosphorylation of phospho-ribosomal protein S6 was also observed, a finding suggestive of downregulation of mTOR signaling. Lastly, we demonstrated that activation of the mTOR pathway in response to L-leucine supplementation was retained, suggesting a possible avenue for directed therapies for this condition.

SUBMITTER: Bhoj EJ 

PROVIDER: S-EPMC4833465 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Through an international multi-center collaboration, 13 individuals from nine unrelated families and affected by likely pathogenic biallelic variants in TBC1-domain-containing kinase (TBCK) were identified through whole-exome sequencing. All affected individuals were found to share a core phenotype of intellectual disability and hypotonia, and many had seizures and showed brain atrophy and white-matter changes on neuroimaging. Minor non-specific facial dysmorphism was also noted in some individu  ...[more]

Similar Datasets

Unknown Homozygous TBC1 domain-containing kinase (TBCK) mutation causes a novel lysosomal storage disease - a new type of neuronal ceroid lipofuscinosis (CLN15)?
| S-EPMC6307319 | biostudies-literature
Unknown Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.
| S-EPMC4375419 | biostudies-literature
Unknown Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features.
| S-EPMC3973091 | biostudies-literature
Unknown Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia.
| S-EPMC4833197 | biostudies-literature
Unknown βIV Spectrinopathies Cause Profound Intellectual Disability, Congenital Hypotonia, and Motor Axonal Neuropathy.
| S-EPMC5992132 | biostudies-literature
Unknown Mutations in MBOAT7, Encoding Lysophosphatidylinositol Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and Autistic Features.
| S-EPMC5065650 | biostudies-literature
Unknown Characterization of a 8q21.11 microdeletion syndrome associated with intellectual disability and a recognizable phenotype.
| S-EPMC3155189 | biostudies-literature
Unknown De novo mutations in FBRSL1 cause a novel recognizable malformation and intellectual disability syndrome.
| S-EPMC7519918 | biostudies-literature
Unknown Biallelic Mutations in UNC80 Cause Persistent Hypotonia, Encephalopathy, Growth Retardation, and Severe Intellectual Disability.
| S-EPMC4716670 | biostudies-literature
Unknown Hypotonia and intellectual disability without dysmorphic features in a patient with PIGN-related disease.
| S-EPMC5668960 | biostudies-literature